Approval · Notice of Compliance 35953 · 2025
NDUVRA: Notice of Compliance 35953
Issued September 3, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35953
- Date
- September 3, 2025
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Merger/Buy-out
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NDUVRA | 02448254 | Marketed |
Medicinal ingredients
- TAPINAROF 1 PER